Overview

18F-FSPG PET/CT in Diagnosing Early Lung Cancer in Patients With Lung Nodules

Status:
Recruiting
Trial end date:
2024-08-01
Target enrollment:
Participant gender:
Summary
This phase II trial studies how well 18F-FSPG positron emission tomography (PET)/computed tomography (CT) work in diagnosing early lung cancer in patients with lung nodules. PET imaging with an imaging agent called 18F-FDG is often used in combination with a PET/CT scanner to evaluate cancers. Giving 18F-FSPG before a PET/CT scan may work better in helping researchers diagnose early lung cancer in patients with lung nodules.
Phase:
Phase 2
Details
Lead Sponsor:
Andrei Iagaru
Stanford University
Collaborators:
Boston University
Canary Foundation
Treatments:
Deoxyglucose
Fluorides
Fluorodeoxyglucose F18